Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies

Reference

• Towne JE, Sims JE. IL-36 in psoriasis. Curr Opin Pharmacol 2012; 12:486-90; PMID:22398321; https://doi.org/10.1016/j.coph.2012.02.009
   PubMed Web of Science ®Google Scholar
• Cowen EW, Goldbach-Mansky R. DIRA, DITRA, and new insights into pathways of skin inflammation: what's in a name? Arch Dermatol 2012; 148:381-4; PMID:22431779; https://doi.org/10.1001/archdermatol.2011.3014
   PubMedGoogle Scholar
• Towne JE, Renshaw BR, Douangpanya J, Lipsky BP, Shen M, Gabel CA, Sims JE. Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36alpha, IL-36beta, and IL-36 gamma) or antagonist (IL-36Ra) activity. J Biol Chem 2011; 286:42594-602; PMID:21965679; https://doi.org/10.1074/jbc.M111.267922
   PubMed Web of Science ®Google Scholar
• Marrakchi S, Guigue P, Renshaw BR, Puel A, Pei XY, Fraitag S, Zribi J, Bal E, Cluzeau C, Chrabieh M, et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med 2011; 365:620-8; PMID:21848462; https://doi.org/10.1056/NEJMoa1013068
   PubMed Web of Science ®Google Scholar
• Blumberg H, Dinh H, Dean C, Jr., Trueblood ES, Bailey K, Shows D, Bhagavathula N, Aslam MN, Varani J, Towne JE, et al. IL-1RL2 and its ligands contribute to the cytokine network in psoriasis. J Immunol 2010; 185:4354-62; PMID:20833839; https://doi.org/10.4049/jimmunol.1000313
   PubMed Web of Science ®Google Scholar

• Sims JE, Nicklin MJ, Bazan JF, Barton JL, Busfield SJ, Ford JE, Kastelein RA, Kumar S, Lin H, Mulero JJ, et al. A new nomenclature for IL-1-family genes. Trends Immunol 2001; 22:536-7; PMID:11574262; https://doi.org/10.1016/S1471-4906(01)02040-3
   PubMed Web of Science ®Google Scholar
• Afonina IS, Muller C, Martin SJ, Beyaert R. Proteolytic Processing of Interleukin-1 Family Cytokines: Variations on a Common Theme. Immunity 2015; 42:991-1004; PMID:26084020; https://doi.org/10.1016/j.immuni.2015.06.003
   PubMed Web of Science ®Google Scholar
• Born TL, Smith DE, Garka KE, Renshaw BR, Bertles JS, Sims JE. Identification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family. Delineation of a new class of IL-1R-related proteins based on signaling. J Biol Chem 2000; 275:29946-54; PMID:10882729; https://doi.org/10.1074/jbc.M004077200
   PubMed Web of Science ®Google Scholar
• Towne JE, Garka KE, Renshaw BR, Virca GD, Sims JE. Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs. J Biol Chem 2004; 279:13677-88; PMID:14734551; https://doi.org/10.1074/jbc.M400117200
   PubMed Web of Science ®Google Scholar
• Thomas C, Bazan JF, Garcia KC. Structure of the activating IL-1 receptor signaling complex. Nat Struct Mol Biol 2012; 19:455-7; PMID:22426547; https://doi.org/10.1038/nsmb.2260
   PubMed Web of Science ®Google Scholar
• Muhr P, Zeitvogel J, Heitland I, Werfel T, Wittmann M. Expression of interleukin (IL)-1 family members upon stimulation with IL-17 differs in keratinocytes derived from patients with psoriasis and healthy donors. Br J Dermatol 2011; 165:189-93; PMID:21410667; https://doi.org/10.1111/j.1365-2133.2011.10302.x
   PubMed Web of Science ®Google Scholar
• Saha SS, Singh D, Raymond EL, Ganesan R, Caviness G, Grimaldi C, Woska JR Jr, Mennerich D, Brown SE, Mbow ML, et al. Signal transduction and intracellular trafficking by the interleukin 36 receptor. J Biolo Chem 2015; 290(39):23997-4006; PMID:26269592; https://doi.org/10.1074/jbc.M115.653378
   PubMed Web of Science ®Google Scholar
• Blumberg H, Dinh H, Trueblood ES, Pretorius J, Kugler D, Weng N, Kanaly ST, Towne JE, Willis CR, Kuechle MK, et al. Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation. J Exp Med 2007; 204:2603-14; PMID:17908936; https://doi.org/10.1084/jem.20070157
   PubMed Web of Science ®Google Scholar
• Onoufriadis A, Simpson MA, Pink AE, Di Meglio P, Smith CH, Pullabhatla V, Knight J, Spain SL, Nestle FO, Burden AD, et al. Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am J hum Genet 2011; 89:432-7; PMID:21839423; https://doi.org/10.1016/j.ajhg.2011.07.022
   PubMed Web of Science ®Google Scholar
• Sugiura K, Takeichi T, Kono M, Ogawa Y, Shimoyama Y, Muro Y, Akiyama M. A novel IL36RN/IL1F5 homozygous nonsense mutation, p.Arg10X, in a Japanese patient with adult-onset generalized pustular psoriasis. Br J Dermatol 2012; 167:699-701; PMID:22428995; https://doi.org/10.1111/j.1365-2133.2012.10953.x
   PubMed Web of Science ®Google Scholar
• Shaik Y, Sabatino G, Maccauro G, Varvara G, Murmura G, Saggini A, Rosati M, Conti F, Cianchetti E, Caraffa A, et al. IL-36 receptor antagonist with special emphasis on IL-38. Int J Immunopathol Pharmacol 2013; 26:27-36; PMID:23527706; https://doi.org/10.1177/039463201302600103
   PubMed Web of Science ®Google Scholar
• Frey S, Derer A, Messbacher ME, Baeten DL, Bugatti S, Montecucco C, Schett G, Hueber AJ. The novel cytokine interleukin-36alpha is expressed in psoriatic and rheumatoid arthritis synovium. Ann Rheum Dis 2013; 72:1569-74; PMID:23268368; https://doi.org/10.1136/annrheumdis-2012-202264
   PubMed Web of Science ®Google Scholar
• Chen H, Wang Y, Bai C, Wang X. Alterations of plasma inflammatory biomarkers in the healthy and chronic obstructive pulmonary disease patients with or without acute exacerbation. J Proteomics 2012; 75:2835-43; PMID:22343073; https://doi.org/10.1016/j.jprot.2012.01.027
   PubMed Web of Science ®Google Scholar
• Medina-Contreras O, Harusato A, Nishio H, Flannigan KL, Ngo V, Leoni G, Neumann PA, Geem D, Lili LN, Ramadas RA, et al. Cutting Edge: IL-36 Receptor Promotes Resolution of Intestinal Damage. J Immunol 2016; 196:34-8; PMID:26590314; https://doi.org/10.4049/jimmunol.1501312
   PubMed Web of Science ®Google Scholar
• Scheibe K, Backert I, Wirtz S, Hueber A, Schett G, Vieth M, Probst HC, Bopp T, Neurath MF, Neufert C. IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivo. Gut 2016; 66(5):823-38; PMID:26783184; https://doi.org/10.1136/gutjnl-2015-310374
   PubMed Web of Science ®Google Scholar
• Russell SE, Horan RM, Stefanska AM, Carey A, Leon G, Aguilera M, Statovci D, Moran T, Fallon PG, Shanahan F, et al. IL-36alpha expression is elevated in ulcerative colitis and promotes colonic inflammation. Mucosal Immunol 2016; 9:1193-204; PMID:26813344; https://doi.org/10.1038/mi.2015.134
   PubMed Web of Science ®Google Scholar
• Wang TS, Chiu HY, Hong JB, Chan CC, Lin SJ, Tsai TF. Correlation of IL36RN mutation with different clinical features of pustular psoriasis in Chinese patients. Arch Dermatol Res 2016; 308:55-63; PMID:26589685; https://doi.org/10.1007/s00403-015-1611-x
   PubMed Web of Science ®Google Scholar
• Sugiura K, Oiso N, Iinuma S, Matsuda H, Minami-Hori M, Ishida-Yamamoto A, Kawada A, Iizuka H, Akiyama M. IL36RN mutations underlie impetigo herpetiformis. J Invest Dermatol 2014; 134:2472-4; PMID:24717243; https://doi.org/10.1038/jid.2014.177
   PubMed Web of Science ®Google Scholar
• Sugiura K. The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants. J Dermatol Sci 2014; 74:187-92; PMID:24656634; https://doi.org/10.1016/j.jdermsci.2014.02.006
   PubMed Web of Science ®Google Scholar
• Shu D, Jin HZ. Mutation analysis of IL36RN in a Chinese Daur family with generalized pustular psoriasis. Eur J Dermatol: EJD 2014; 24:415-6; PMID:24979538; https://doi.org/10.1684/ejd.2014.2382
   PubMed Web of Science ®Google Scholar
• Renert-Yuval Y, Horev L, Babay S, Tams S, Ramot Y, Zlotogorski A, Molho-Pessach V. IL36RN mutation causing generalized pustular psoriasis in a Palestinian patient. Int J Dermatol 2014; 53:866-8; PMID:24898045; https://doi.org/10.1111/ijd.12525
   PubMed Web of Science ®Google Scholar
• Li X, Chen M, Fu X, Zhang Q, Wang Z, Yu G, Yu Y, Qin P, Wu W, Pan F, et al. Mutation analysis of the IL36RN gene in Chinese patients with generalized pustular psoriasis with/without psoriasis vulgaris. J Dermatol Sci 2014; 76:132-8; PMID:25212972; https://doi.org/10.1016/j.jdermsci.2014.08.007
   PubMed Web of Science ®Google Scholar
• Hayashi M, Nakayama T, Hirota T, Saeki H, Nobeyama Y, Ito T, Umezawa Y, Fukuchi O, Yanaba K, Kikuchi S, et al. Novel IL36RN gene mutation revealed by analysis of 8 Japanese patients with generalized pustular psoriasis. J Dermatol Sci 2014; 76:267-9; PMID:25468355; https://doi.org/10.1016/j.jdermsci.2014.10.008
   PubMed Web of Science ®Google Scholar
• Carapito R, Isidor B, Guerouaz N, Untrau M, Radosavljevic M, Launay E, Cassagnau E, Frenard C, Aubert H, Romefort B, et al. Homozygous IL36RN mutation and NSD1 duplication in a patient with severe pustular psoriasis and symptoms unrelated to deficiency of interleukin-36 receptor antagonist. Br J Dermatol 2014; 172(1):302-5; PMID:25039711; http://dx.doi.org/10.1111/bjd.13261
   PubMed Web of Science ®Google Scholar
• Berki DM, Mahil SK, Burden AD, Trembath RC, Smith CH, Capon F, Barker JN. Loss of IL36RN function does not confer susceptibility to psoriasis vulgaris. J Invest Dermatol 2014; 134:271-3; PMID:23792462; https://doi.org/10.1038/jid.2013.285
   PubMed Web of Science ®Google Scholar
• Setta-Kaffetzi N, Navarini AA, Patel VM, Pullabhatla V, Pink AE, Choon SE, Allen MA, Burden AD, Griffiths CE, Seyger MM, et al. Rare pathogenic variants in IL36RN underlie a spectrum of psoriasis-associated pustular phenotypes. J Invest Dermatol 2013; 133:1366-9; PMID:23303454; https://doi.org/10.1038/jid.2012.490
   PubMed Web of Science ®Google Scholar
• Navarini AA, Valeyrie-Allanore L, Setta-Kaffetzi N, Barker JN, Capon F, Creamer D, Roujeau JC, Sekula P, Simpson MA, Trembath RC, et al. Rare variations in IL36RN in severe adverse drug reactions manifesting as acute generalized exanthematous pustulosis. J Invest Dermatol 2013; 133:1904-7; PMID:23358093; https://doi.org/10.1038/jid.2013.44
   PubMed Web of Science ®Google Scholar
• Li M, Lu Z, Cheng R, Li H, Guo Y, Yao Z. IL36RN gene mutations are not associated with sporadic generalized pustular psoriasis in Chinese patients. Br J Dermatol 2013; 168:452-5; PMID:22862555; https://doi.org/10.1111/j.1365-2133.2012.11195.x
   PubMed Web of Science ®Google Scholar
• Korber A, Mossner R, Renner R, Sticht H, Wilsmann-Theis D, Schulz P, Sticherling M, Traupe H, Hüffmeier U. Mutations in IL36RN in patients with generalized pustular psoriasis. J Invest Dermatol 2013; 133:2634-7; PMID:23648549; https://doi.org/10.1038/jid.2013.214
   PubMed Web of Science ®Google Scholar
• Kanazawa N, Nakamura T, Mikita N, Furukawa F. Novel IL36RN mutation in a Japanese case of early onset generalized pustular psoriasis. J Dermatol 2013; 40:749-51; PMID:23834760; https://doi.org/10.1111/1346-8138.12227
   PubMed Web of Science ®Google Scholar
• Farooq M, Nakai H, Fujimoto A, Fujikawa H, Matsuyama A, Kariya N, Aizawa A, Fujiwara H, Ito M, Shimomura Y. Mutation analysis of the IL36RN gene in 14 Japanese patients with generalized pustular psoriasis. Human mutat 2013; 34:176-83; PMID:22903787; https://doi.org/10.1002/humu.22203
   PubMed Web of Science ®Google Scholar
• Capon F. IL36RN mutations in generalized pustular psoriasis: just the tip of the iceberg? J Invest Dermatol 2013; 133:2503-4; PMID:24129779; https://doi.org/10.1038/jid.2013.361
   PubMed Web of Science ®Google Scholar
• Singh S, Kroe-Barrett RR, Canada KA, Zhu X, Sepulveda E, Wu H, He Y, Raymond EL, Ahlberg J, Frego LE, et al. Selective targeting of the IL23 pathway: Generation and characterization of a novel high-affinity humanized anti-IL23A antibody. mAbs 2015; 7:778-91; PMID:25905918; https://doi.org/10.1080/19420862.2015.1032491
   PubMed Web of Science ®Google Scholar
• Wu H, An LL. Tailoring kinetics of antibodies using focused combinatorial libraries. Methods Mol Biol 2003; 207:213-33; PMID:12412477; https://doi.org/10.1385/1-59259-334-8:213
   PubMedGoogle Scholar
• De Groot AS, Scott DW. Immunogenicity of protein therapeutics. Trends Immunol 2007; 28:482-90; PMID:17964218; https://doi.org/10.1016/j.it.2007.07.011
   PubMed Web of Science ®Google Scholar
• Urlaub G, Kas E, Carothers AM, Chasin LA. Deletion of the diploid dihydrofolate reductase locus from cultured mammalian cells. Cell 1983; 33:405-12; PMID:6305508; https://doi.org/10.1016/0092-8674(83)90422-1
   PubMed Web of Science ®Google Scholar
• Arduin E, Arora S, Bamert PR, Kuiper T, Popp S, Geisse S, Grau R, Calzascia T, Zenke G, Kovarik J. Highly reduced binding to high and low affinity mouse Fc gamma receptors by L234A/L235A and N297A Fc mutations engineered into mouse IgG2a. Mol Immunol 2015; 63:456-63; PMID:25451975; https://doi.org/10.1016/j.molimm.2014.09.017
   PubMed Web of Science ®Google Scholar
• Baudino L, Shinohara Y, Nimmerjahn F, Furukawa J, Nakata M, Martinez-Soria E, Petry F, Ravetch JV, Nishimura S, Izui S. Crucial role of aspartic acid at position 265 in the CH2 domain for murine IgG2a and IgG2b Fc-associated effector functions. J Immunol 2008; 181:6664-9; PMID:18941257; https://doi.org/10.4049/jimmunol.181.9.6664
   PubMed Web of Science ®Google Scholar
• Tortola L, Rosenwald E, Abel B, Blumberg H, Schafer M, Coyle AJ, Renauld JC, Werner S, Kisielow J, Kopf M. Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk. J Clin Invest 2012; 122:3965-76; PMID:23064362; https://doi.org/10.1172/JCI63451
   PubMed Web of Science ®Google Scholar
• Gkalpakiotis S, Arenberger P, Gkalpakioti P, Hugo J, Sticova E, Tesinsky P, Arenbergerová M. A case of acute generalized pustular psoriasis of von Zumbusch treated with adalimumab. J Eur Acad Dermatol Venereol 2015; 29:2063-4; PMID:24981161; https://doi.org/10.1111/jdv.12597
   PubMed Web of Science ®Google Scholar
• Bohner A, Roenneberg S, Eyerich K, Eberlein B, Biedermann T. Acute Generalized Pustular Psoriasis Treated With the IL-17A Antibody Secukinumab. JAMA Dermatol 2015:1-2; PMID:26650014; https://doi.org/10.1001/jamadermatol.2015.4686
   Web of Science ®Google Scholar
• Huffmeier U, Watzold M, Mohr J, Schon MP, Mossner R. Successful therapy with anakinra in a patient with generalized pustular psoriasis carrying IL36RN mutations. Br J Dermatol 2014; 170:202-4; PMID:23909475; https://doi.org/10.1111/bjd.12548
   PubMed Web of Science ®Google Scholar
• Rondeau JM, Ramage P, Zurini M, Gram H. The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta. mAbs 2015; 7:1151-60; PMID:26284424; https://doi.org/10.1080/19420862.2015.1081323
   PubMed Web of Science ®Google Scholar
• De Groot AS, Martin W. Reducing risk, improving outcomes: bioengineering less immunogenic protein therapeutics. Clini Immunol 2009; 131:189-201; PMID:19269256; https://doi.org/10.1016/j.clim.2009.01.009
   PubMed Web of Science ®Google Scholar
• Schuck P. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys J 2000; 78:1606-19; PMID:10692345; https://doi.org/10.1016/S0006-3495(00)76713-0
   PubMed Web of Science ®Google Scholar
• Cohen SB, Proudman S, Kivitz AJ, Burch FX, Donohue JP, Burstein D, Sun YN, Banfield C, Vincent MS, Ni L, et al. A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee. Arthritis Res Ther 2011; 13:R125; PMID:21801403; https://doi.org/10.1186/ar3430
   PubMed Web of Science ®Google Scholar